@FiercePharma: Top-read pharma news this weekend: Actavis plan to stop making original Namenda derailed by court. Article | Follow @FiercePharma
@EricPFierce: ICMYI from FiercePharmaManufacturing: Third round of cuts slated for Novartis US Diovan plant. Total reaches 133 with 394 more gone by 2016. Piece | Follow @EricPFierce
@CarlyHFierce: The only thing that makes me happier on a Monday than a vaccines M&A story is one that involves the Czech Republic. Press release | Follow @CarlyHFierce
> Roche's ($RHHBY) Genentech unit submitted a marketing application to U.S. regulators for the use of its experimental drug Cobimetinib with cancer med Zelboraf to treat an advanced form of skin cancer. More
> Novartis ($NVS) revealed positive late-stage Phase IIIb study data showing that its experimental psoriasis med Cosentyx was better at clearing rough patches of skin than Johnson & Johnson's ($JNJ) rival drug Stelara. Story
> Biocon is planning to set up a new manufacturing facility in Vizag, Visakhapatnam, India. More
> A judge ordered Texas' Department of Criminal Justice to release the name of the compounding pharmacy that provides lethal drugs used in state executions. More
Medical Device News
@FierceMedDev: ICYMI Friday: Strong one-year data for $BSX chronic pain implant, but reimbursement change stymies sales. Article | Follow @FierceMedDev
@StacyALawrence: How Long Can We Expect to Live? U.S. Life Expectancy Hits Record High. More | Follow @StacyALawrence
@EmilyWFierce: IRS battles it out with Medtronic and Covidien over offshore tax paying tactic. Story | Follow @EmilyWFierce
> GE-backed InSightec gets $59M for noninvasive surgical tool, adds ex-Mako CEO to board. Report
> FDA issues new guidance on MRI safety and compatibility of medical devices. More
> Spinal device maker LDR files to raise $150M. Article
Biotech News
@FierceBiotech: Novartis quarterbacks a $34M round for Huntington's startup Annexon. Report | Follow @FierceBiotech
@JohnCFierce: Who spends $295M upfront on a me-better Ph3 growth hormone? $PFE, that's who. Spending money like it's 1998. Release | Follow @JohnCFierce
@DamianFierce: $SNY and $REGN bought CholesterolCounts.com ahead of their expected PCSK9 launch. | Follow @DamianFierce
> Broad's David Altshuler tapped as new CSO at Vertex. More
> Sophiris plummets on doubts its prostate drug can clear Phase III. Article
> Onyx vet Tony Coles embarks on a new biotech adventure. Report
CRO News
> BioClinica snags a Pfizer exec to take the helm. Item
> CRO Health Decisions carries on after CEO's death. More
> Medidata burnishes its risk-based monitoring tech with latest buy. Report
> DaVita grows its in-house CRO with a data-centric merger. Story
> PPD's X-Chem pairs up with Alexion for drug discovery. Article
Biotech IT News
> Autism Speaks to make Google-underpinned genomics database freely available. More
> Early Medidata backer plans $150M digital-health fund. Article
> Pfizer turns to app to overcome rare disease enrollment bottleneck. Item
> Flatiron maintains dealmaking pace with patient-reported outcome data hookup. Story
> Transcriptic offers Y Combinator biotechs $20,000 credit for its robotic labs. Report
Animal Health News
> Parnell shakes up management team, woos investors, as shares stagnate. News
> Kansas State researchers model U.S. outbreak of foot-and-mouth. Report
> European and U.S. scientists warn veterinary meds are endangering wildlife. More
> Will the $8.2B buyout of PetSmart affect its in-store Banfield pet hospitals? Story
> Sanofi chairman hints at animal health deals, sending Zoetis shares soaring. Article
And Finally… The European Medicines Agency (EMA) found that anti-inflammatory livestock drug diclofenac is a threat to vultures and other carcass-eating birds in Europe. Story